EVQLV is at the forefront of transforming the design and development of therapeutic antibodies through the application of computational advances. The company collaborates with partners in the discovery stage to expedite antibody discovery processes. For collaborators with assets at various stages, including preclinical, clinical, or commercial, EVQLV provides support for optimizing antibody candidates, expanding intellectual p...
EVQLV is at the forefront of transforming the design and development of therapeutic antibodies through the application of computational advances. The company collaborates with partners in the discovery stage to expedite antibody discovery processes. For collaborators with assets at various stages, including preclinical, clinical, or commercial, EVQLV provides support for optimizing antibody candidates, expanding intellectual property (IP) protection, and designing innovative immunotherapies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.